Loading
Albemarle Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 07 Nov 2023.
Albemarle Corp: what insiders have been doing
Albemarle Corp, classified in the Chemicals & Materials sector, is a listed company based in Baton Rouge, United States, founded in 1994. Its insiders report their share dealings to SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 62 filings came from 17 insiders.
Only sales appear on the open market, 7 sales in all totalling €5.4M, filed by 4 insiders. At €1.9M, the sale published on 19 May 2026 by Masters J Kent is the largest of the period (0.014% of market cap).
With 62 filings in twelve months, the company is more active than the median of 19 filings across the 5,812 companies we follow on the same exchange. The full history, which starts in 2016, counts 6 purchases against 36 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 5.14 bn USD and net income at -510.6 m USD; the dividend was 1.62 USD per share.
Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Other companies in the same sector with recent insider buying flagged by our signals: Culp Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
248
Thresholds
n/a
Buy Volume
€2M
6 ops. · all time
Sell Volume
€16M
36 ops. · all time
Who traded when
BuySaleJ. Kent Masters5 sales
Ander C. Krupa2 sales
Eric Norris1 sale
Melissa H. Anderson1 sale
Netha N. Johnson1 sale
Since the insiders bought
- -16.0%Entry US$119.01 · Close at T+365 US$99.93
- -33.2%Entry US$195.17 · Close at T+365 US$130.46
- +26.1%Entry US$191.85 · Close at T+365 US$241.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Albemarle Corp Buy (bullish), based on 21 analysts. Average price target: US$163.11.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,394 of 24,148 companies
23.7
score / 100
Value31
Quality17
FCF yld6.1%
Earn yld-6.0%
EV/EBITDA46.3x
ROE2.6%
Gross mgn13%
Net mgn-13%
Debt/EBITDA10.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$97.97
Analyst consensus
21 analystsBuy
US$83.28Target US$163.11(+66%)US$225.00
Income statement
RevenueUS$5.1B
Gross profitUS$668.7M13% margin
EBITDAUS$314.3M6% margin
Net income-US$677.4M3.8% margin
Valuation
PER (trailing)362.9x
PER (forward)8.7x
P/Book1.4x
Beta1.36
Balance sheet & cash
Market capUS$11.6B
Total debtUS$3.3B
Free Cash FlowUS$692.5M
Debt / Equity19%
Profitability & ownership
ROE2.6%
ROA3.2%
% insiders0.2%
% institutions101.8%
Last declaration on 2 October 2026
Declarations248 total
45 shares0Common StockSEC:0000915913-26-000120:0
5,217 shares0Common StockSEC:0000915913-26-000113:0
6,086 shares0Common StockSEC:0000915913-26-000114:0
10,867 shares0Common StockSEC:0000915913-26-000115:0
1,375 shares0Common StockSEC:0000915913-26-000097:0
929 shares@ US$136.080.0009% mcap98.6% of flowCommon StockSEC:0001913598-26-000002:1
13 shares@ US$136.080.0000% mcap1.4% of flowCommon StockSEC:0001913598-26-000002:3
33 shares0Common StockSEC:0001585657-26-000007:0
1,250 shares0Common StockSEC:0001235612-26-000002:0
1,250 shares0Common StockSEC:0002047429-26-000010:0
36 shares0Common StockSEC:0001235612-26-000002:1
1,250 shares0Common StockSEC:0001730941-26-000002:0
1,250 shares0Common StockSEC:0001143210-26-000003:0
36 shares0Common StockSEC:0001143210-26-000003:1
36 shares0Common StockSEC:0001730941-26-000002:1
1,250 shares0Common StockSEC:0001913598-26-000002:0
36 shares0Common StockSEC:0001913598-26-000002:2
2 shares0Common StockSEC:0002047429-26-000010:1
11,867 shares@ US$183.870.014% mcap25.5% of flowCommon StockSEC:0000915913-26-000080:1
700 shares@ US$184.520.0008% mcap1.5% of flowCommon StockSEC:0000915913-26-000080:2
3,826 shares@ US$183.120.0045% mcap8.2% of flowCommon StockSEC:0000915913-26-000080:0
25 shares0Common StockSEC:0000915913-26-000062:0
5,395 shares@ US$170.2610.8% of flowCommon StockSEC:0001396415-26-000010:0
32 shares0Common StockSEC:0001585657-26-000004:2
25 of 248 declarations
About Albemarle Corp
Albemarle Corp. (NYSE: ALB) is a U.S.-based specialty chemicals company listed on the New York Stock Exchange in the United States, with headquarters in Charlotte, North Carolina. The company’s roots date back to 1887, while Albemarle Corporation became a publicly traded entity in 1994. Over time, the business has evolved from its historical industrial and paper heritage into a more focused specialty-chemicals platform centered on lithium, bromine and catalysts. ([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf))
Today, Albemarle positions itself as one of the world’s largest lithium suppliers and an industry leader in bromine solutions. Its main operating pillars are lithium solutions, bromine solutions and catalysts. The lithium franchise includes lithium hydroxide, lithium carbonate, lithium metal and specialty organometallics and salts used in batteries for electric vehicles, energy storage and broader industrial applications. The bromine portfolio spans flame retardants, industrial water treatment, fire safety, environmental remediation and drilling-fluid applications, while its catalyst business serves refining and petrochemical customers. This mix gives the company exposure to both energy-transition demand and more traditional industrial end markets. ([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf))
Read moreShow less
Geographically, Albemarle has a broad global footprint and serves customers in approximately 70 countries. The company highlights a differentiated asset base that includes the only operating lithium mine in the United States, alongside brine assets in Chile, hard-rock and JV assets in Australia, and conversion and R&D facilities across North America, South America, Europe and Asia. That integration from mine and brine to finished chemicals is a key competitive advantage, supporting supply reliability and product quality. ([albemarle.com](https://www.albemarle.com/sites/default/files/2025-04/Albemarle-Corporate-FactSheet-2025-27-03_2.pdf))
From a competitive standpoint, Albemarle benefits from scale, resource quality, technical know-how and long-standing customer relationships. At the same time, the company remains highly sensitive to lithium price cycles, which have weighed on earnings and capital allocation in recent periods. Recent corporate updates show a more disciplined operating posture: during 2025 the company emphasized cost and productivity actions, and in February 2026 it announced plans to idle the remaining operating train at its Kemerton lithium hydroxide processing plant in Western Australia to preserve financial flexibility. Albemarle’s full-year 2025 results also pointed to positive operating cash flow and meaningful free cash flow generation, with 2026 capex guided to remain roughly flat versus 2025. For investors, the name therefore combines strategic exposure to electrification with a still-cyclical earnings profile. ([investors.albemarle.com](https://investors.albemarle.com/news-and-events/news/news-details/2026/Albemarle-Reports-Fourth-Quarter-and-Full-Year-2025-Results/default.aspx?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
